Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
The Journal of Laboratory and Clinical Medicine|April 1, 1994
Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal functionJ T McCarthy, A W Williams, W J JohnsonMayo Clinic Proceedings|May 1, 1985
Elevated bone aluminum content in dialysis patients without osteomalaciaJ T McCarthy, S B Kurtz, J T McCallThe American Journal of Medicine|February 1, 1987
Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysisJ T McCarthy, S B Kurtz, G V MussmanAmerican Journal of Physiology. Endocrinology and Metabolism|February 9, 2000
Reduced synthesis of muscle proteins in chronic renal failureD Adey, R Kumar, J T McCarthy, et al.Mayo Clinic Proceedings|May 1, 1993
Detection of subtle aluminum-related renal osteodystrophyS A Romanski, J T McCarthy, K Kluge, et al.Mayo Clinic Proceedings|November 18, 1998
Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot studyD A O'Sullivan, J T McCarthy, R Kumar, et al.Radiology|August 1, 1987
Aluminum toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy resultsJ S Kriegshauser, R G Swee, J T McCarthy, et al.ANNA Journal|April 1, 1994
Clinical benefits of high and variable sodium concentration dialysate in hemodialysis patientsB M Jenson, S A Dobbe, D P Squillace, et al.The American Journal of Gastroenterology|May 12, 1998
Renal and urologic complications of inflammatory bowel diseaseD S Pardi, W J Tremaine, W J Sandborn, et al.Mayo Clinic Proceedings|July 1, 1982
Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapyJ T McCarthy, C R Libertin, J C Mitchell, et al.Pageof 7